$1 million grant supports research on groundbreaking therapies for MS

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

AstraZeneca’s rare blood disorder pill approved in Japan

AstraZeneca’s add-on pill for the rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH) won its first approval in Japan, the company announced Friday. The drug, an

January 20, 2024

AI-powered method predicts protein dynamics to accelerate drug discovery

Understanding the structure of proteins is critical for demystifying their functions and developing drugs that target them.

March 27, 2024

Study investigates the serious health issues faced by Aboriginal and Torres Strait Islander people

A landmark research project will place health workers in Indigenous communities across Queensland to study the long-term wellbeing of Aboriginal and Torres Strait Islander families.

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.